KOVACERT Trademark

Trademark Overview

On Wednesday, October 12, 2005, a trademark application was filed for KOVACERT with the United States Patent and Trademark Office. The USPTO has given the KOVACERT trademark a serial number of 78731999. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 16, 2009. This trademark is owned by Immunex Corporation. The KOVACERT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of oncological diseases and disorders and complications associated therewith
kovacert

General Information

Serial Number78731999
Word MarkKOVACERT
Filing DateWednesday, October 12, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 16, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2006

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of oncological diseases and disorders and complications associated therewith

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 18, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmunex Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameImmunex Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Monday, November 16, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 16, 2009ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 25, 2009EXTENSION 5 GRANTED
Tuesday, March 24, 2009EXTENSION 5 FILED
Tuesday, March 24, 2009TEAS EXTENSION RECEIVED
Thursday, September 18, 2008EXTENSION 4 GRANTED
Monday, September 15, 2008EXTENSION 4 FILED
Thursday, September 18, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 15, 2008TEAS EXTENSION RECEIVED
Friday, April 11, 2008EXTENSION 3 GRANTED
Thursday, March 13, 2008EXTENSION 3 FILED
Thursday, March 13, 2008TEAS EXTENSION RECEIVED
Monday, September 24, 2007EXTENSION 2 GRANTED
Tuesday, September 11, 2007EXTENSION 2 FILED
Tuesday, September 11, 2007TEAS EXTENSION RECEIVED
Tuesday, July 17, 2007EXTENSION 1 GRANTED
Monday, April 2, 2007EXTENSION 1 FILED
Monday, April 2, 2007TEAS EXTENSION RECEIVED
Tuesday, October 17, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 26, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 25, 2006PUBLISHED FOR OPPOSITION
Wednesday, July 5, 2006NOTICE OF PUBLICATION
Tuesday, June 6, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 26, 2006ASSIGNED TO LIE
Thursday, May 11, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 11, 2006EXAMINER'S AMENDMENT ENTERED
Thursday, May 11, 2006EXAMINERS AMENDMENT E-MAILED
Thursday, May 11, 2006EXAMINERS AMENDMENT -WRITTEN
Thursday, May 11, 2006PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, May 2, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 2, 2006EXAMINER'S AMENDMENT ENTERED
Tuesday, May 2, 2006EXAMINERS AMENDMENT E-MAILED
Tuesday, May 2, 2006EXAMINERS AMENDMENT -WRITTEN
Sunday, April 23, 2006NON-FINAL ACTION E-MAILED
Sunday, April 23, 2006NON-FINAL ACTION WRITTEN
Sunday, April 16, 2006ASSIGNED TO EXAMINER
Tuesday, October 18, 2005NEW APPLICATION ENTERED IN TRAM

Related Keywords

kovacert complications associated therewith disorders diseases preparations treatment oncological pharmaceutical